William Blair Has Bearish Forecast for BMY FY2026 Earnings
Equities research analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Bristol-Myers ...
Science Daily14h
Co-located cell types help drive aggressive brain tumors
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
Investor's Business Daily on MSN19h
Stock Market Sideways Amid Trump Tariff, Inflation Fears; Palantir, Google, Amazon Among Key Movers: Weekly Review
The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were ...
Armed robbery in Revesby19h
Cell Types Co-located Drive Aggressive Brain Tumors
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...
Bristol-Myers Squibb: Solid Q4 Earnings, But Weak Guidance And Patent Concerns Drive The Stock Down
Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...
Model Portfolio For Capital Appreciation, February 2025
Top stock picks for capital appreciation and outperformance, with a focus on profits, dividends, and long-term viability. Click for more on Capital Appreciation.
sharewise23h
Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
Shares of The Bristol-Myers Squibb Company (NYSE: BMY)are attempting to claw their way back into positive territory after the ...
Bristol-Myers Squibb Company (NYSE:BMY) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...